APA (7th ed.) Citation

Felix Korell, Stefan Schönland, Anita Schmitt, Madelaine Jansen, Kiavasch Farid, Carsten Müller-Tidow, . . . Ute Hegenbart. (2023). First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma. BMC.

Chicago Style (17th ed.) Citation

Felix Korell, Stefan Schönland, Anita Schmitt, Madelaine Jansen, Kiavasch Farid, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, and Ute Hegenbart. First Third-generation CAR T Cell Application Targeting CD19 for the Treatment of Systemic IgM AL Amyloidosis with Underlying Marginal Zone Lymphoma. BMC, 2023.

MLA (9th ed.) Citation

Felix Korell, et al. First Third-generation CAR T Cell Application Targeting CD19 for the Treatment of Systemic IgM AL Amyloidosis with Underlying Marginal Zone Lymphoma. BMC, 2023.